About
Copy Link
Titles
Hospital Resident
Biography
Jonathan Tefera is a resident physician in Interventional Radiology at Yale New Haven Hospital. His clinical and research interests focus on minimally invasive cancer therapies, particularly in liver cancer. Dr. Tefera has led studies on portal vein embolization and was recognized with the RSNA Trainee Research Prize. He brings a strong background in translational oncology and remains dedicated to advancing patient-centered, image-guided interventions.
Last Updated on December 03, 2025.
Departments & Organizations
Education & Training
- MD
- Charite University (2022)
Research
Copy Link
Overview
Medical Research Interests
Liver Cirrhosis; Liver Neoplasms
ORCID
0000-0001-9038-8579
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jonathan Tefera's published research.
Publications Timeline
A big-picture view of Jonathan Tefera's research output by year.
Research Interests
Research topics Jonathan Tefera is interested in exploring.
Julius Chapiro, MD, PhD
David C. Madoff, MD
Annabella Shewarega, MD
Xuchen Zhang, MD, PhD
Todd Schlachter, MD
Fabian Max Laage Gaupp, MD
12Publications
256Citations
Liver Neoplasms
Liver Cirrhosis
Publications
2026
CT Radiomics to Predict Regenerative Biomarker Expression after Liver Venous Embolization: Proof-of-Concept in a Porcine Model
Nguyenová J, Yang J, Zhang X, Shewarega A, Tefera J, Kuhn T, Gebauer B, Savic L, Chapiro J, Madoff D. CT Radiomics to Predict Regenerative Biomarker Expression after Liver Venous Embolization: Proof-of-Concept in a Porcine Model. Journal Of Vascular And Interventional Radiology 2026, 108895. PMID: 42269821, DOI: 10.1016/j.jvir.2026.108895.Peer-Reviewed Original ResearchHepatic Augmentation
Tefera J, Madoff D. Hepatic Augmentation. 2026, 505-526. DOI: 10.1007/978-3-032-03935-4_33.BooksRobotics in Interventional Oncology: A Call to Arms?
Tefera J, Ghosn Y, Cornelis F, Madoff D. Robotics in Interventional Oncology: A Call to Arms? Current Oncology Reports 2026, 28: 32. PMID: 41912756, DOI: 10.1007/s11912-026-01775-6.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNeoadjuvant PD-1 Inhibition prior to Partial Cryoablation of Murine Hepatocellular Carcinoma Modulates the Tumor Microenvironment toward Favorable Immunological Profiles
Kao T, Santana J, Meister E, Shewarega A, Israel J, Peschke L, Tefera J, Matuschewski N, Sobirey R, Zhang X, Gebauer B, Madoff D, Savic L, Chapiro J. Neoadjuvant PD-1 Inhibition prior to Partial Cryoablation of Murine Hepatocellular Carcinoma Modulates the Tumor Microenvironment toward Favorable Immunological Profiles. Journal Of Vascular And Interventional Radiology 2026, 37: 108585. PMID: 41690670, PMCID: PMC13052828, DOI: 10.1016/j.jvir.2026.108585.Peer-Reviewed Original ResearchAltmetric
2025
Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
Matuschewski N, Sobirey R, Revzin M, Zeevi T, Gross M, Kasolowsky V, Shewarega A, Meister E, Kao T, Tefera J, Bousabarah K, Batra R, Strazzabosco M, Lin M, Gebauer B, Savic L, Duncan J, Madoff D, Zhang X, Chapiro J. Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma. Radiology 2025, 316: e242750. PMID: 40762840, PMCID: PMC12405729, DOI: 10.1148/radiol.242750.Peer-Reviewed Original ResearchCitationsAltmetricPortal and Hepatic Vein Embolization versus Portal Venous Embolization Alone in Cirrhotic and Noncirrhotic Swine: A Pilot Study
Tefera J, Kuhn T, Matuschewski N, Meister E, Nguyenová J, Kao T, Mutonga M, Bitar R, Kahl V, Zhang X, Shewarega A, Chapiro J, Madoff D. Portal and Hepatic Vein Embolization versus Portal Venous Embolization Alone in Cirrhotic and Noncirrhotic Swine: A Pilot Study. Journal Of Vascular And Interventional Radiology 2025, 36: 1042-1050.e2. PMID: 40043833, DOI: 10.1016/j.jvir.2025.02.028.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8+ T-Cell Infiltration in Murine Hepatocellular Carcinoma.
Shewarega A, Santana J, Nam D, Berz A, Tefera J, Kahl V, Mishra S, Coman D, Duncan J, Roberts S, Wetter A, Madoff D, Chapiro J. Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8+ T-Cell Infiltration in Murine Hepatocellular Carcinoma. Radiology 2024, 310: e232365. PMID: 38349244, PMCID: PMC10902598, DOI: 10.1148/radiol.232365.Peer-Reviewed Original ResearchCitationsAltmetric
2022
Prinzipien der nicht-chirurgischen lokoregionären Therapie
Tefera J, Savic L, Gebauer B. Prinzipien der nicht-chirurgischen lokoregionären Therapie. Springer Reference Medizin 2022, 1-10. DOI: 10.1007/978-3-662-46764-0_179-1.Books
2020
Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI
Doemel LA, Chapiro J, Laage Gaupp F, Savic LJ, Kucukkaya AS, Petukhova A, Tefera J, Zeevi T, Lin M, Schlachter T, Jaffe A, Strazzabosco M, Patel T, Stein SM. Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI. European Radiology 2020, 31: 2737-2746. PMID: 33123796, PMCID: PMC8043967, DOI: 10.1007/s00330-020-07381-9.Peer-Reviewed Original ResearchCitationsAltmetricAutomated detection and delineation of hepatocellular carcinoma on multiphasic contrast-enhanced MRI using deep learning
Bousabarah K, Letzen B, Tefera J, Savic L, Schobert I, Schlachter T, Staib LH, Kocher M, Chapiro J, Lin M. Automated detection and delineation of hepatocellular carcinoma on multiphasic contrast-enhanced MRI using deep learning. Abdominal Radiology 2020, 46: 216-225. PMID: 32500237, PMCID: PMC7714704, DOI: 10.1007/s00261-020-02604-5.Peer-Reviewed Original ResearchCitationsAltmetric
Get In Touch
Copy Link